Report Highlights Impact of Medical Misdiagnosis of TB and Fungal Infection

Article

Researchers have discovered that more than 1 million people worldwide diagnosed with tuberculosis (TB) go on to develop an incurable but manageable fungal infection which is usually left untreated because it is mistaken for a recurrence of the disease.

In a new report published today in the Bulletin of the World Health Organization, the researchers from University of Manchester and University of Toronto say because the X-ray features and symptoms are so similar doctors often misdiagnose and prescribe the wrong treatment which can lead to tens of thousands of unnecessary deaths.

The fungal infection responsible, chronic pulmonary aspergillosis (CPA), evades the immune system in the lungs progressing slowly and may lie undetected for years until symptoms (weight loss, tiredness, coughing and bleeding) start to develop. By then it is often too late to treat successfully. Fifty percent of all patients who develop it are unlikely to survive for more than five years, a similar outlook to many cancers.

Now, the report's authors are calling on the World Health Organisation and others to provide awareness training, particularly for medics in Africa, India and China where under diagnosis of CPA is even more common than in Western countries because of the burden of TB.

The team was led by professor David Denning, director of the National Aspergillosis Centre at the University Hospital of South Manchester. He says the report highlights huge global variations in frequency and survival. "For example, only 17 percent of referred CPA patients in Manchester had underlying TB compared with 93 percent in Korea. This variation reflects differences in diagnosis and inappropriate therapyor none at all. Identifying CPA early in patients is only possible by means of microbiological testing for Aspergillus antibodies."

Donald Cole, associate professor and division head of global health at the University of Toronto's Dalla Lana School of Public Health, is an expert in environmental and public health. He believes doctors have probably underestimated the worldwide burden of CPA. "We based our estimates on WHO data but the information is robust in some countries but not others. Under reporting is common, especially in countries such as China."

Ian Jacobs is director of MAHSCa partnership between the NHS in Manchester and the University of Manchesterand has recently included global health as a focus for its work. He is backing the call for WHO and the leaders of countries in Asia and Africa to take action. "TB is a major scourge worldwide, and to find that more than one-third of a million people each year then develop an incurable and ultimately fatal fungal complicationwhich could be diagnosed and treateddemands action."

Related Videos
NFID Medical Director, Robert H. Hopkins, Jr., MD  (Photo courtesy by Evoke Kyne)
Shelley Summerlin-Long, MPH, MSW, BSN, RN, senior quality improvement leader, infection prevention, UNC Medical Center, Chapel Hill, North Carolina
Infection Control Today Infection Intel: Staying Ahead with Company updates and product Innovations.
An eye instrument holding an intraocular lens for cataract surgery. How to clean and sterilize it appropriately?   (Adobe Stock 417326809By Mohammed)
Christopher Reid, PhD  (Photo courtesy of Christopher Reid, PhD)
Paper with words antimicrobial resistance (AMR) and glasses.   (Adobe Stock 126570978 by Vitalii Vodolazskyi)
3D illustration: Candida auris   (Adobe Stock 635576411 By Niamh )
 MIS-C (Adobe Stock 350657530 by Bernard Chantal)
Set of white bottles with cleaning liquids on the white background. (Adobe Stock 6338071172112 by zolnierek)
Related Content